• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人急性髓系白血病的可测量残留病:多维“雷达”流式细胞术图谱分析方法的评估。

Measurable residual disease in adult acute myeloid leukaemia: evaluation of a multidimensional 'radar' flow cytometric plot analysis method.

机构信息

Department of Laboratory Haematology, ICPMR, Westmead Hospital, NSW Health Pathology, Westmead, NSW, Australia; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.

Flow Cytometry Unit, ICPMR, NSW Health Pathology, Westmead Hospital, Westmead, NSW, Australia.

出版信息

Pathology. 2023 Apr;55(3):383-390. doi: 10.1016/j.pathol.2022.10.007. Epub 2022 Dec 30.

DOI:10.1016/j.pathol.2022.10.007
PMID:36725446
Abstract

Measurable residual disease (MRD) monitoring in acute myeloid leukaemia (AML) is becoming increasingly important and is predominantly performed by multiparameter flow cytometry (MFC) or quantitative polymerase chain reactions (RT-qPCR). We investigated the use of multidimensional plots (MD-MFC) for AML MRD monitoring in an adult cohort. AML MRD was determined using a novel MD-MFC method for 115 MRD samples. Results were correlated with traditional two-dimensional MFC (2D-MFC) and molecular methods. Using the standard cut-off of 0.1% CD45+ cells, concordance was 99/115 (p=0.332). Eighty-four of 115 were concordant using a very low reporting limit of 0.01% (p=0.216). MRD <0.1% by either method was present in 40 of 115 samples. Fifteen of 40 were MD-MFC positive and 2D-MFC negative. Of these two of 15 had a molecular MRD marker and both were positive. Molecular MRD markers were available in 36 of 115 cases. Twenty-one of 36 (58%) were concordant with MD-MFC. Eight of 36 had detectable molecular MRD only and eight of 36 had positive MD-MFC only. There was no correlation between either the MFC method and the molecular results. In summary, there is good correlation between MD- and 2D-MFC-MRD and no correlation between the MFC and molecular methods.

摘要

在急性髓系白血病(AML)中,可测量残留疾病(MRD)监测变得越来越重要,主要通过多参数流式细胞术(MFC)或实时定量聚合酶链反应(RT-qPCR)进行。我们研究了多维图(MD-MFC)在成人队列中用于 AML MRD 监测的应用。使用一种新的 MD-MFC 方法对 115 个 MRD 样本进行 AML MRD 测定。结果与传统二维 MFC(2D-MFC)和分子方法相关联。使用 0.1% CD45+细胞的标准截止值,99/115(p=0.332)个样本一致。使用非常低的报告限值 0.01%,84/115(p=0.216)个样本一致。两种方法均为 MRD<0.1%的样本为 40/115。这 40 个样本中有 15 个 MD-MFC 阳性而 2D-MFC 阴性。这 15 个中有 2 个分子 MRD 标志物呈阳性,且均为阳性。在 115 个病例中有 36 个有分子 MRD 标志物。36 个中有 21 个与 MD-MFC 一致。36 个中有 8 个仅有可检测到的分子 MRD,36 个中有 8 个仅有阳性 MD-MFC。MFC 方法与分子结果之间没有相关性。总之,MD-MFC 和 2D-MFC-MRD 之间相关性良好,而 MFC 和分子方法之间没有相关性。

相似文献

1
Measurable residual disease in adult acute myeloid leukaemia: evaluation of a multidimensional 'radar' flow cytometric plot analysis method.成人急性髓系白血病的可测量残留病:多维“雷达”流式细胞术图谱分析方法的评估。
Pathology. 2023 Apr;55(3):383-390. doi: 10.1016/j.pathol.2022.10.007. Epub 2022 Dec 30.
2
Indeterminate measurable residual disease by multiparameter flow cytometry is associated with an intermediate risk of clinical relapse in adult patients with acute leukaemia.多参数流式细胞术检测到的不确定可测量残留病与成人急性白血病患者临床复发的中等风险相关。
Pathology. 2024 Oct;56(6):882-888. doi: 10.1016/j.pathol.2024.04.009. Epub 2024 Jun 26.
3
Fusion transcript analysis reveals slower response kinetics than multiparameter flow cytometry in childhood acute myeloid leukaemia.融合转录本分析显示,在儿童急性髓细胞白血病中,其反应动力学比多参数流式细胞术更慢。
Int J Lab Hematol. 2022 Dec;44(6):1094-1101. doi: 10.1111/ijlh.13935. Epub 2022 Aug 2.
4
The applicability of multiparameter flow cytometry for the detection of minimal residual disease using different-from-normal panels to predict relapse in patients with acute myeloid leukemia after allogeneic transplantation.多参数流式细胞术使用不同于正常的面板检测微小残留病在异基因移植后急性髓系白血病患者中的应用,以预测复发。
Int J Lab Hematol. 2019 Oct;41(5):607-614. doi: 10.1111/ijlh.13070. Epub 2019 Jun 4.
5
Minimal/Measurable Residual Disease Detection in Acute Leukemias by Multiparameter Flow Cytometry.多参数流式细胞术检测急性白血病中的微小/可测量残留病
Curr Hematol Malig Rep. 2018 Dec;13(6):455-466. doi: 10.1007/s11899-018-0479-1.
6
Prognostic value of combined WT1 and multiparameter flow cytometry assessment for measurable residual disease after induction in non-APL acute myeloid leukemia.WT1 联合多参数流式细胞术评估在非 APL 急性髓细胞白血病诱导后可测量残留病中的预后价值。
Scand J Clin Lab Invest. 2023 Sep;83(5):340-347. doi: 10.1080/00365513.2023.2227946. Epub 2023 Jun 24.
7
Test Then Erase? Current Status and Future Opportunities for Measurable Residual Disease Testing in Acute Myeloid Leukemia.检测后清除?急性髓系白血病中可测量残留疾病检测的现状和未来机遇。
Acta Haematol. 2024;147(2):133-146. doi: 10.1159/000535463. Epub 2023 Nov 30.
8
Comparison of Multiparameter Flow Cytometry Immunophenotypic Analysis and Quantitative RT-PCR for the Detection of Minimal Residual Disease of Core Binding Factor Acute Myeloid Leukemia.多参数流式细胞术免疫表型分析与定量逆转录聚合酶链反应检测核心结合因子急性髓系白血病微小残留病的比较
Am J Clin Pathol. 2016 Jun;145(6):769-77. doi: 10.1093/ajcp/aqw038. Epub 2016 Jun 12.
9
The role of multiparameter flow cytometry for disease monitoring in AML.多参数流式细胞术在 AML 疾病监测中的作用。
Best Pract Res Clin Haematol. 2010 Sep;23(3):379-90. doi: 10.1016/j.beha.2010.06.007. Epub 2010 Aug 12.
10
Post-Transplantation Day +100 Minimal Residual Disease Detection Rather Than Mixed Chimerism Predicts Relapses after Allogeneic Stem Cell Transplantation for Intermediate-Risk Acute Myelogenous Leukemia Patients Undergoing Transplantation in Complete Remission.移植后第 +100 天微小残留病灶检测而非嵌合状态预测完全缓解后接受异基因造血干细胞移植的中危急性髓系白血病患者的复发。
Transplant Cell Ther. 2022 Jul;28(7):374.e1-374.e9. doi: 10.1016/j.jtct.2022.04.009. Epub 2022 Apr 13.